Cargando…
Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
Stereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management particularly in the medically inoperable patients. Retrospective studies have shown this to be well tolerated with comparable results to surgery and no significant increase in toxicity. Paucity of rand...
Autores principales: | Yahya, Sundus, Ghafoor, Qamar, Stevenson, Robert, Watkins, Steven, Allos, Beshar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163903/ https://www.ncbi.nlm.nih.gov/pubmed/30041469 http://dx.doi.org/10.3390/medicines5030077 |
Ejemplares similares
-
Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience
por: Lee, Justin, et al.
Publicado: (2021) -
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012) -
Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014) -
Current status of stereotactic ablative body radiotherapy in the UK: six years of progress
por: Distefano, Gail, et al.
Publicado: (2019) -
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011)